Skip to content

Depression: all studies

Page 94 of 1,034: studies 931 to 940 of 10,336, newest first. Back to the depression overview

Research

The effect of esketamine on postoperative anxiety and depression in patients with thyroid cancer: A randomized, double-blind, placebo-controlled, parallel-group trial.

Medicine May 2, 2025 Xiaobo Bi, Junchao Dai, Jin Li 8 citations

This study aimed to investigate the effects of a single intravenous injection of esketamine during general anesthesia on postoperative anxiety and depression in patients with thyroid cancer. In this randomized, double-blind, placebo-controlled, parallel-group trial, eighty female patients with thyroid cancer were scheduled to undergo surgery under general anesthesia. The patients were randomly...

DOI: 10.1097/MD.0000000000042284 (opens in new tab) Full text (opens in new tab) Affective symptoms Postoperative complication Thyroid cancer surgery Esketamine therapy +3

0564 Trait Mindfulness Protects Against the Harmful Effects of Nocturnal Cognitive Arousal on Insomnia and Depression Symptoms in Pregnancy and Postpartum

Sleep May 1, 2025 Mika Hirata, Heba A Afaneh, Ishana Kapoor et al.

Perinatal women are highly vulnerable to insomnia and depression. High cognitive arousal (e.g., worry, rumination) at night is a key risk factor for developing insomnia and depression during this period. However, mindfulness skills have been proposed to reduce risk for negative health outcomes by protecting individuals against the harmful effects of cognitive arousal. This prospective study...

Ketamine for unipolar major depression: critical examination of antidepressant effects

BJPsych Advances May 1, 2025 Aditya Patel

SUMMARYThis critical appraisal of a Cochrane Review assesses the efficacy of ketamine for treating unipolar major depressive disorder. The review included 31 randomised controlled trials involving ketamine. Results indicate that intravenous (i.v.) ketamine significantly improves antidepressant response compared with i.v. saline and, to a lesser extent, i.v. midazolam within 24–72 h. However,...

The Efficacy and Durability of Mindfulness-Based Cognitive Therapy in the Treatment of Anxiety and Depressive Disorders: A Systematic Review and Meta-analysis.

Indian Journal of Psychological Medicine May 1, 2025 Nikapitiye Nandarathana, Jay Kumar Ranjan 17 citations

There is a dearth of meta-analytical studies measuring the durability of mindfulness-based cognitive therapy (MBCT) in the treatment of anxiety and depressive disorders. Therefore, the present study was conducted to evaluate both the effectiveness and durability of MBCT in the treatment of depression and anxiety disorders. We systematically searched six databases from June 11, 2023 to September...

The effects of the Mindfulness-Based Childbirth and Parenting Program (MBCP) on prenatal attachment, depression, stress, and anxiety in pregnant women: A randomized controlled trial.

Journal of Affective Disorders May 1, 2025 Ezgi Fındık, Neslihan Yılmaz Sezer, Menekşe Nazlı Aker et al. 11 citations

Interventions to cope with emotional states (depression, stress, and anxiety) and strengthen attachment are important. This research aims to determine the effect of the Mindfulness-Based Childbirth and Parenting Program (MBCP) on pregnant women's prenatal attachment and their levels of depression, stress, and anxiety. This randomized controlled trial included 36 participants who were randomly...

DOI: 10.1016/j.jad.2025.02.030 (opens in new tab) Full text (opens in new tab) Mental health Prenatal attachment Prenatal stress Randomized controlled trial

The Evaluation of the Adjunctive Therapeutic Value of Mindfulness-Based Stress Reduction Therapy for Patients With Nasopharyngeal Carcinoma Induced Moderate Depression.

Actas Españolas de Psiquiatría May 1, 2025 Zeyu Zheng, Jing Han

Nasopharyngeal carcinoma (NPC) presents a substantial challenge for patients, impacting their physical and psychological well-being. Patients may experience moderate depression, anxiety, and reduced quality of life due to the disease and its treatments. Therefore, we retrospectively analyzed the adjunctive therapeutic potential of mindfulness-based stress reduction (MBSR) therapy for NPC...

Mindfulness in treatment-seeking adults with comorbid obsessive-compulsive and major depressive disorders: Mediating effects of obsessive beliefs and mental well-being.

Indian Journal of Psychiatry May 1, 2025 Mohammad Asif Sheikh, Thaddeus Alfonso 1 citation

Mindfulness-based interventions have shown promise in alleviating symptoms associated with obsessive-compulsive disorder (OCD) and major depressive disorder (MDD). However, the specific mechanisms that drive these effects, mainly through obsessive beliefs and mental well-being, are seldom examined. To explore the mechanisms by which mindfulness influences symptom severity in adults with...

Understanding and treating postpartum depression: a narrative review.

International Clinical Psychopharmacology May 1, 2025 Vincenzo Cardaci, Matteo Carminati, Mattia Tondello et al. 7 citations

Postpartum depression (PPD) is an increasingly prevalent but still poorly characterized disorder. Causal and modulating factors include hormones fluctuations, such as estrogen, progesterone, and allopregnolone, pathways imbalances, such as oxytocin and kynurenine, chronobiological factors, and brain imaging alterations. Treatment may differ from the traditional major depression management,...

DOI: 10.1097/YIC.0000000000000560 (opens in new tab) Full text (opens in new tab) Postpartum depression ppd Postnatal depression Maternal wellness Behavioral therapy +2

Relative effectiveness of antidepressant treatments in treatment-resistant depression: a systematic review and network meta-analysis of randomized controlled trials.

Neuropsychopharmacology May 1, 2025 Johan Saelens, Anna Gramser, Victoria Watzal et al. 47 citations

This systematic review and network meta-analysis (NMA) sought to compare different antidepressant treatments for treatment-resistant depression (TRD) in order to facilitate evidence-based choices. A literature search of PubMed, Cochrane Library, and Embase from inception until April 13th, 2023 identified randomized, controlled trials (RCTs) of adults with depression who had not responded to at...

DOI: 10.1038/s41386-024-02044-5 (opens in new tab) Full text (opens in new tab) Treatment-resistant depression Depression treatment Electroconvulsive therapy Mental health interventions +1

Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study.

Journal of Affective Disorders May 1, 2025 Alessandro Cuomo, Simone Pardossi, Giovanni Barillà et al. 7 citations

Ketamine's use in treating bipolar depression must account for risks, such as switching to manic episodes or worsening symptoms. This study examines ketamine's impact on depressive symptoms, focusing on 'inner tension,' 'sleep reduction,' and 'suicidal ideation' over four weeks in treatment-resistant bipolar disorder (TR-BD) patients. Fifty-nine patients with TR-BD were treated consecutively...

DOI: 10.1016/j.jad.2025.01.059 (opens in new tab) Full text (opens in new tab) Bipolar disorder Mental health treatment Ketamine therapy Bipolar depression +2